Sarepta Therapeutics' shares plunged nearly 30% on Tuesday as the failure of two of its approved drugs in a key trial and ...

A new study finds adults who use melatonin for a year or more may face a sharply increased risk of heart failure. Sleep ...

The Georgia Republican sharply criticized her party during an appearance on "The View," but focused her remarks on ...

Former American tennis pro Sam Querrey analyzed Carlos Alcaraz's chances at the ATP Finals 2025, and made a daring ...

The AI Village—an experiment run by nonprofit Sage—set up models from OpenAI, Anthropic, Google, and xAI to collaborate and ...

Following his explosive debut, Monangai, who is looking like the biggest steal in the 2025 NFL draft, will now make his debut ...

The Dolphins could have a new coach any time it suits team owner Stephen Ross. But as long as Tagovailoa is healthy, the ...

Judge Builder addresses what Pallavi Koppol, a Databricks research scientist who led the development, calls the "Ouroboros problem." An Ouroboros is an ancient symbol that depicts a snake eating its ...

Auburn will pay $15.8 million to make Freeze go away, the latest eight-figure payment the university has approved for a failed football coach. In just the last five years, that number totals more than ...

Juventus resume their underwhelming Champions League campaign today with a must-win home clash against Sporting CP. Allianz ...

The latest setback comes after Sarepta's top-selling gene therapy, Elevidys, was briefly pulled from the market in July ...